Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Haystack Oncology
301 West 29th Street, STE. 2004U
Baltimore, MD 21211
https://haystackoncology.com/

Haystack Oncology uses the next generation of circulating tumor DNA (ctDNA) detection technology to see through the noise and uncover the lowest levels of ctDNA in blood to report residual, recurrent, or resistant disease earlier than any other minimal residual disease (MRD) test. Designed by cancer genomics pioneers and liquid biopsy experts, Haystack's tumor-informed MRD test is best positioned to deliver the right treatment to the right person at the right time. Haystack is based in Baltimore, MD, USA, and has research facilities in Hamburg, Germany.

Key Contact
Name
Dan Edelstein
Title
CEO
E-Mail
Funding Events

Date
Amount
Type
Investors
Valuation
11/16/22 $56,000,000 Series A Bruker Corporation
Catalio Capital
Exact Ventures
undisclosed


Featured Reading